tivicay dolutegravir (as sodium) 25 mg film-coated tablet bottle
viiv healthcare pty ltd - dolutegravir sodium, quantity: 26.3 mg (equivalent: dolutegravir, qty 25 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; sodium stearylfumarate; mannitol; microcrystalline cellulose; povidone; polyvinyl alcohol; titanium dioxide; macrogol 3350; purified talc; iron oxide yellow - tivicay and tivicay pd are indicated for the treatment of human immunodeficiency virus (hiv) infection in combination with other antiretroviral agents in adults and children of at least 4 weeks in age or older and weighing 3 kg or more (see section 4.4 special warnings and precautions for use, dual regimens).
tivicay 10 mg
glaxo smith kline (israel) ltd - dolutegravir as sodium - film coated tablets - dolutegravir as sodium 10 mg - dolutegravir - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg
tivicay 25 mg
glaxo smith kline (israel) ltd - dolutegravir as sodium - film coated tablets - dolutegravir as sodium 25 mg - dolutegravir - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg
tivicay 50 mg
glaxo smith kline (israel) ltd - dolutegravir as sodium - film coated tablets - dolutegravir as sodium 50 mg - dolutegravir - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children above 6 years of age.
tivicay 50 mg
glaxo smith kline (israel) ltd - dolutegravir as sodium - film coated tablets - dolutegravir as sodium 50 mg - dolutegravir - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg.
dolutegravir
hetero labs ltd - dolutegravir - tablet; oral - 50mg
dolutegravir
aurobindo pharma limited - dolutegravir - tablet, coated; oral - 50 mg
dolutegravir
mylan laboratories limited - dolutegravir - tablet; oral - 50mg
dolutegravir
cipla ltd - dolutegravir - tablet, coated; oral - 50mg
dolutegravir (sodium)
sun pharmaceutical industries limited - dolutegravir - tablet, coated; oral - 50mg